Fenbendazole is a broad-spectrum benzimidazole anthelmintic originally developed for veterinary use to treat parasitic infections in animals. It has been widely used since the 1970s and is known for its excellent safety profile.
In recent years, fenbendazole has gained significant attention for its potential anticancer properties, largely following the story of Joe Tippens, who reported his cancer remission while using fenbendazole as part of his treatment protocol.
How Does Fenbendazole Work?
Fenbendazole works by binding to beta-tubulin, a structural protein essential for cell division. This disrupts microtubule formation, which is critical for both parasites and cancer cells to grow and divide. Research suggests fenbendazole may also:
- Inhibit glucose uptake in cancer cells
- Reactivate the p53 tumor suppressor gene
- Reduce angiogenesis (new blood vessel formation that feeds tumors)
- Promote apoptosis (programmed cell death) in cancer cells
Is Fenbendazole Safe for Humans?
Fenbendazole is a veterinary anthelmintic and is not FDA-approved for human use. Animal tolerability does not establish safety for people, and no human anticancer dose has been established. An early antiparasitic study does not establish the safety of prolonged cancer-treatment regimens. Published case reports describe liver injury after self-administration, including biopsy-confirmed severe drug-induced liver injury and a case in a patient receiving pembrolizumab. Tell your treating team about any use and discuss medication interactions and liver-function monitoring; monitoring does not make an untested regimen safe.
Some users have reported mild side effects such as:
- Temporary gastrointestinal discomfort
- Mild elevation of liver enzymes (usually reversible)
- Occasional fatigue during initial use
It is always recommended to consult with a healthcare professional before starting any new supplement.
What Is the Joe Tippens Protocol?
The Joe Tippens Protocol is one of the most well-known fenbendazole-based cancer protocols. It typically includes:
- Fenbendazole: 222 mg taken 3 consecutive days per week, then 4 days off
- Vitamin E: 800 IU daily (tocotrienols preferred)
- Curcumin: 600 mg daily (bioavailable form)
- CBD oil: 25 mg daily
Many users have modified this protocol based on their specific needs and the guidance of their healthcare providers.
What Dosage Should I Take?
The 222 mg 3-days-on / 4-days-off schedule is an informal regimen associated with the Joe Tippens story, not an established human cancer dose. Veterinary package instructions are not human dosing instructions, and higher or continuous doses promoted online are not validated cancer-treatment regimens. ASCO advises against using fenbendazole to treat cancer, or as an adjunct to established therapies, outside a well-designed clinical trial. This page does not prescribe a dose.
This page does not give starting doses, escalation schedules or tolerance-testing advice. Any use of an unapproved veterinary drug should be discussed with a qualified healthcare professional, who can review interactions with other medicines and arrange liver-function monitoring.
Where Can I Buy Quality Fenbendazole?
Quality matters significantly when choosing fenbendazole. Look for products that are:
- Laboratory tested for purity (99%+ purity)
- Manufactured in GMP-certified facilities
- Third-party verified with Certificates of Analysis (COA)
- Properly dosed in capsule form for consistent dosing
You can browse our curated selection of tested and rated fenbendazole products in our Product Reviews & Ratings section.
Can Fenbendazole Be Taken with Other Medications?
Fenbendazole has relatively few known drug interactions. However, it is metabolized by the liver, so caution is advised when combining with other liver-metabolized drugs. Consult your healthcare provider, especially if you are taking:
- Chemotherapy drugs
- Blood thinners
- Immunosuppressants
- Other anthelmintic medications
How Long Before I See Results?
There is no evidence-based timeline for cancer response to fenbendazole. Reports of improvement within weeks or months cannot establish that fenbendazole caused the change, particularly when other treatments were given. A published case report described liver injury without tumour shrinkage during self-administration. A frequently cited three-patient case series was retracted in January 2026 after an undeclared conflict of interest by the first author. Do not delay established cancer treatment while waiting for an unproven effect.
Disclaimer
This page is for informational purposes only and does not constitute medical advice. Fenbendazole is not FDA-approved for human use. Always consult a qualified healthcare professional before starting any new treatment or supplement regimen.
